| Literature DB >> 28009836 |
Veli Bakalov1, Roland Amathieu2,3, Mohamed N Triba4, Marie-Jeanne Clément5, Laura Reyes Uribe6, Laurence Le Moyec7, Ata Murat Kaynar8,9.
Abstract
Patients surviving sepsis demonstrate sustained inflammation, which has been associated with long-term complications. One of the main mechanisms behind sustained inflammation is a metabolic switch in parenchymal and immune cells, thus understanding metabolic alterations after sepsis may provide important insights to the pathophysiology of sepsis recovery. In this study, we explored metabolomics in a novel Drosophila melanogaster model of surviving sepsis using Nuclear Magnetic Resonance (NMR), to determine metabolite profiles. We used a model of percutaneous infection in Drosophila melanogaster to mimic sepsis. We had three experimental groups: sepsis survivors (infected with Staphylococcus aureus and treated with oral linezolid), sham (pricked with an aseptic needle), and unmanipulated (positive control). We performed metabolic measurements seven days after sepsis. We then implemented metabolites detected in NMR spectra into the MetExplore web server in order to identify the metabolic pathway alterations in sepsis surviving Drosophila. Our NMR metabolomic approach in a Drosophila model of recovery from sepsis clearly distinguished between all three groups and showed two different metabolomic signatures of inflammation. Sham flies had decreased levels of maltose, alanine, and glutamine, while their level of choline was increased. Sepsis survivors had a metabolic signature characterized by decreased glucose, maltose, tyrosine, beta-alanine, acetate, glutamine, and succinate.Entities:
Keywords: NMR; metabolomics; sepsis; survival
Year: 2016 PMID: 28009836 PMCID: PMC5192453 DOI: 10.3390/metabo6040047
Source DB: PubMed Journal: Metabolites ISSN: 2218-1989
Figure 11H NMR spectral region between 0.5 and 6 ppm of Drosophila samples from the umanipulated (bottom), sham (middle), and sepsis survivor (top) groups. The main resonances are labeled according to metabolite assignments of the Table 1.
Figure 2OPLS model comparing unmanipulated (blue) and sham (red) groups. The score plot (A) shows the variability of each sample according to their groups with Tpred axis representing the predictive axis and Torth, the orthogonal axis. Each dot corresponds to a spectrum; The loading plot (B) shows the covariance of the spectral bins colored according to the R values between the model and the belonging group. Positive signals correspond to metabolites present at increased concentrations in the sham group. Conversely, negative signals correspond to metabolites present at increased concentrations in the unmanipulated group.
Figure 3OPLS model comparing sham (blue) and sepsis survivors (red) groups. The score plot (A) shows the variability of each sample according to their groups with Tpred axis representing the predictive axis and Torth, the orthogonal axis. Each dot corresponds to a spectrum. The loading plot (B) shows the covariance of the spectral bins colored according to the R values between the model and the corresponding group. Positive signals correspond to metabolites present at increased concentrations in sepsis survivors group; negative signals correspond to metabolites present at increased concentrations in the sham group.
Main metabolites detected in 1H-NMR spectra with their chemical shift and labels presented in Figure 1. The correlation coefficient R between the OPLS model and the signal intensity is given for the model computed between sham and sepsis survivors.
| Peak Labels in | Chemical Shift | Assignment | | |
|---|---|---|---|
| 1 | 0.9; 1.28 | Fatty acid methyl and methylene moieties | |
| 2 | 0.98–1.05 | Leucine, Isoleucine, Valine | |
| 3 | 1.33 | Lactate | |
| 4 | 1.48 | Alanine | |
| 5 | 1.92 | Acetate | −0.525 |
| 6 | 2.03; 2.16; 2.34 | Glutamine + Glutamate | −0.542 |
| 7 | 2.41 | Succinate | −0.708 |
| 8 | 2.56 | Beta-alanine | −0.676 |
| 9 | 2.75 | Dimethylamine (DMA) | |
| 10 | 3.01 | Lysine | |
| 11 | 3.22 | Choline | |
| 12 | 3.23–4.0; 4.62; 5.23 | Glucose | −0.725 |
| 13 | 3.5–4.0; 4.45; 5.42 | Maltose | −0.701 |
| 14 | 4.1; 4.15 | Glycerol | |
| not shown | 7.12 | Methyl-histidine | |
| not shown | 7.94 | Histidine | |
| not shown | 6.89; 7.20 | Tyrosine | −0.667 |
Figure 4Summary of the metabolic pathways in Drosophila melanogaster involved in the metabolic adaptation in sepsis survivors compared to sham. (A) is the Metexplore extracted sub-pathway with metabolites down-regulated are colored in yellow and those detected and not modulated are colored in blue; (B) shows the metabolites detected not modulated in the metabolomic profile in blue while the metabolites down-modulated are colored in red.